<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="3" ids="44915">Propofol</z:chebi> is reported to have protective effects on <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>-induced neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to explore whether <z:chebi fb="3" ids="44915">propofol</z:chebi> and <z:chebi fb="2" ids="5615">halothane</z:chebi> can protect hippocampal neuronal function from ischaemic injury during general anaesthesia in rats </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Rats were divided into 2-vessel occlusion (incomplete <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>) and 4-vessel occlusion (complete <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>) groups consisting of three subgroups each (sham-operated, <z:chebi fb="3" ids="44915">propofol</z:chebi> and <z:chebi fb="2" ids="5615">halothane</z:chebi> groups) </plain></SENT>
<SENT sid="3" pm="."><plain>One hour after starting <z:chebi fb="3" ids="44915">propofol</z:chebi> 1 mg kg(-1) min(-1) with 30% O2 and N2 or <z:chebi fb="2" ids="5615">halothane</z:chebi> 0.8% in 30% O2 and N2 rats with or without bilateral vertebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> had bilateral common carotid arteries occluded by vessel clips for 10 min </plain></SENT>
<SENT sid="4" pm="."><plain>Anaesthesia was maintained for another 1 h </plain></SENT>
<SENT sid="5" pm="."><plain>Seven days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-reperfusion, hippocampal long-term potentiation in the perforant path-dentate gyrus synapse was determined as an index of cerebral outcome </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In the <z:chebi fb="3" ids="44915">propofol</z:chebi> groups, the formation of long-term potentiation was significantly impaired in the 2-vessel and 4-vessel occlusion groups compared to the respective sham-operated groups (P &lt; 0.01 and P &lt; 0.05, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Impaired formation of long-term potentiation in <z:chebi fb="3" ids="44915">propofol</z:chebi> groups was comparable to that in <z:chebi fb="2" ids="5615">halothane</z:chebi> groups </plain></SENT>
<SENT sid="8" pm="."><plain>The formation of long-team potentiation in the <z:chebi fb="3" ids="44915">propofol</z:chebi> and <z:chebi fb="2" ids="5615">halothane</z:chebi> 2-vessel group was not significantly different from that in the awake 2-vessel group </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:chebi fb="3" ids="44915">Propofol</z:chebi> and <z:chebi fb="2" ids="5615">halothane</z:chebi> administered during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> do not possess protective effects against hippocampal neuronal dysfunction induced by <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>-reperfusion as evaluated by our transient ischaemic rat models </plain></SENT>
</text></document>